MedPath

Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer
Registration Number
NCT06495736
Lead Sponsor
Yunnan Cancer Hospital
Brief Summary

The goal of this clinical trial is to evaluate the value of rapid on-site evaluation(ROSE) in lymph node biopsy of breast cancer. The main question it aims to answer is:The ROSE technique was applied to breast cancer lymph node biopsy to improve the diagnostic efficiency and accuracy.

Participants underwent routine lymph node biopsy, and the test personnel conducted routine disease examination and rose technique evaluation on the removed ly

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • Patients had pathologically confirmed primary breast cancer
  • Surgical treatment was available
Exclusion Criteria
  • Previous history of surgery on the affected axilla, internal breast or chest
  • Pregnant or breastfeeding patients
  • Previous radiotherapy or chemotherapy
  • Complicated history of other tumors

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The number of positive and negative lymph nodes diagnosed by ROSE techniqueup to 2 years
Secondary Outcome Measures
NameTimeMethod
The time taken to diagnose using the ROSE techniqueup to 2 years

Trial Locations

Locations (1)

Yunnan Cancer Hospital

🇨🇳

Kunming, Yunnan, China

© Copyright 2025. All Rights Reserved by MedPath